Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.
Scirica
Benjamin M
BM
TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Morrow
David A
DA
D000818:Animals; D001057:Apolipoproteins E / Q000502:physiology; D050197:Atherosclerosis / Q000097:blood / Q000209:etiology*; D015415:Biomarkers; D002097:C-Reactive Protein / Q000032:analysis / Q000037:antagonists & inhibitors / Q000633:toxicity*; D042783:Endothelial Cells / Q000187:drug effects; D006801:Humans; D023421:Models, Animal
D001057:Apolipoproteins E; D015415:Biomarkers; D002097:C-Reactive Protein